RESPONSE TIMES FOR ACUTE NON-INVASIVE VENTILATION SET-UPS

Abstract

NIV is a lifesaving treatment in chronic obstructive pulmonary disease (COPD). Prompt NIV treatment in hypercapnic COPD exacerbations allows for improved physiological outcomes, reduced intubation rates and shortened hospital stay in (1, 2). Therefore, consensus expert opinion is that prompt application of acute NIV substantially reduces the risk of death and should be started without delay in appropriately selected patients with acute hypercapnic respiratory failure (AHRF).The ‘door-to-mask’ time (hospital arrival to NIV commencement: target ≤120 minutes) has been widely used to measure the quality of acute NIV services as per the 2018